Synthetic peptides have become everyday reagents. Hospital research units, academic labs and contract research organisations use them to study metabolism, wound healing, immunology and neuroscience. Demand has grown so quickly that the supplier market now ranges from established chemical houses to small online vendors. For procurement and lab managers, that creates a familiar healthcare problem: the product looks identical on the label, but the quality behind it can vary enormously.
Poor reagents do not just waste budget. An impure or mislabelled peptide can invalidate months of experiments, contaminate cell lines and produce results nobody can reproduce. A clear supplier standard prevents most of it.
The five tests that matter
1. Purity by HPLC
High-performance liquid chromatography (HPLC) separates the target peptide from impurities such as truncated or incompletely deprotected sequences left over from synthesis. Purity is reported as a percentage of the total peak area. For most research uses, 98% or higher is the expected standard, and the chromatogram itself should be on the report, not just the number.
2. Identity by mass spectrometry
HPLC tells you how pure a sample is, not what it is. Mass spectrometry confirms that the molecular weight matches the intended sequence. A purity result without an identity result is incomplete.
3. Net peptide content
This is the most overlooked number. A vial labelled 10 mg contains 10 mg of powder, but that powder also includes water and counter-ions (often trifluoroacetate from purification). Net peptide content, typically measured by amino acid analysis or quantitative methods, tells you how much of that mass is actually peptide. It commonly runs well below 100%, and it directly affects every concentration you calculate.
4. Endotoxin testing for cell and animal work
Endotoxins are fragments of bacterial cell walls that trigger strong immune responses at tiny concentrations. For any work with live cells or animals, an endotoxin result (usually by the LAL assay) should be requested, because endotoxin contamination can mimic or mask the very inflammatory effects being studied.
5. Batch traceability
Every certificate of analysis (COA) should carry a lot number that matches the vial delivered. A generic“representative” COA is not evidence about the material on your bench.
A procurement checklist
| Requirement | What to ask for | Red flag | |
| Independent testing | COA from a named third-party lab | In-house testing only, or no lab named | |
| Lot matching | COA lot number equals vial lot number | One COA reused for every batch | |
| Purity | HPLC chromatogram, at least 98% | A percentage with no chromatogram | |
| Identity | Mass spectrometry result | No identity test | |
| Content | Net peptide content or quantitative assay | Label weight only | |
| Labelling | Clear research-use-only statements | Human-use claims, dosing advice | |
| Storage and shipping | Lyophilised product, storage guidance, protective packaging | No storage instructions | |
Why independent and repeated testing matters
A single test from a single lab is a snapshot. Better suppliers re-test as new batches arrive and use more than one independent laboratory, which reduces the risk of a lab-specific error going unnoticed. Some, such as NextGenPeps, publish a public COA library from multiple independent labs so buyers can review results before ordering, rather than requesting them afterwards.
That transparency is becoming a useful filter. When comparing suppliers of research peptides, a vendor that publishes lot-matched results openly is giving procurement teams something they can verify.
Building it into policy
1. Write the standard down. Add peptide-specific requirements (purity, identity, content, lot-matched COA) to your approved-supplier criteria.
2. Verify on receipt. Check every delivered lot number against its COA before the material enters inventory.
3. Retain documentation. File COAs with experimental records so results can be traced back to a specific batch.
4. Re-qualify periodically. Supplier quality can change; review approved vendors at least annually.
5. Respect the label. Research-use-only material must stay in the lab and never enter clinical supply.
Research is only as reliable as its reagents. Treating peptides with the same supplier discipline applied to pharmaceuticals and medical devices protects budgets, timelines and the integrity of the science.
This article is for educational purposes. Research peptides are intended for laboratory research only and are not for human or veterinary use.